gentamicin has been researched along with pasireotide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodmer, D; Horvath, L; Kucharava, K; Petkovic, V; Sekulic-Jablanovic, M | 1 |
1 other study(ies) available for gentamicin and pasireotide
| Article | Year |
|---|---|
Pasireotide protects mammalian cochlear hair cells from gentamicin ototoxicity by activating the PI3K-Akt pathway.
Topics: Animals; Anti-Bacterial Agents; Female; Gentamicins; Hair Cells, Auditory; Hearing Loss; Hormones; Humans; Male; Mice; Ototoxicity; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Somatostatin | 2019 |